로딩 중…
StockDiggingStockDigging

Abbott Laboratories

ABT· NYSE
$88.41-0.10%
2026-06-18

Price Chart

Abbott Laboratories-32.29%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$153.99B
Revenue$45.13B
Net Income$6.28B
Total Assets$110.43B
Net Assets$52.06B
Employees115,000
Value
P/E24.54x
P/B2.96x
P/S3.41x
EV/EBITDA16.78x
FCF Yield4.79%
Profitability
ROE12.06%
ROA5.68%
Op. Margin18.17%
Revenue Growth7.78%
Earnings Growth-18.72%
Financial Health
Debt Ratio110.89%
Total Debt$34.05B
FCF$7.38B
Cash$6.80B
Current Ratio1.39x
Net Debt/EBITDA2.52x
Dividend
Div. Yield2.72%
Div. Growth6.36%
Performance
1Y Return-32.29%
1M Return-0.46%
From 52W High-35.53%
1Y MDD-39.37%
Trading
Volume10,373,268 shares
Trading Value$918M
Per Share
EPS$3.73
BPS$29.84

Company Info

CEO Mr. Robert B. Ford
Employees 115,000
HQ Abbott Park, United States

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.